Regístrese
Buscar en
Revista Colombiana de Reumatología
Toda la web
Inicio Revista Colombiana de Reumatología Historia sobre el papel de las hormonas y los anticonceptivos en el lupus
Información de la revista
Vol. 18. Núm. 1.
Páginas 8-25 (Marzo 2011)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 18. Núm. 1.
Páginas 8-25 (Marzo 2011)
DOI: 10.1016/S0121-8123(11)70059-7
Acceso a texto completo
Historia sobre el papel de las hormonas y los anticonceptivos en el lupus
History on the role of hormones and contraceptives in lupus
Visitas
3422
Édgar Peñaranda-Parada1, Rafael Méndez Fandiño2, Federico Rondón-Herrera3, José Félix Restrepo-Suárez4, Gerardo Quintana5, Antonio Iglesias-Gamarra4,
Autor para correspondencia
iglesias.antonio1@gmail.com

Correspondencia: Los autores declaran no presentar ningún conflicto de interés al momento de la redacción del manuscrito.
1 Residente en Reumatología, Universidad Nacional de Colombia
2 Residente en Medicina Interna, Universidad del Rosario
3 Especialista en Reumatología, Profesor Asociado Facultad de Medicina, Universidad Nacional
4 Especialista en Reumatología, Profesor Titular Facultad de Medicina, Universidad Nacional
5 Especialista en Reumatología, Profesor Asistente Facultad de Medicina Universidad Nacional
Este artículo ha recibido
3422
Visitas
Información del artículo
Resumen
Bibliografía
Descargar PDF
Estadísticas
Resumen

En este artículo presentamos los diferentes eventos que llevaron a conocer a profundidad la interrelación que existe entre las hormonas y el lupus, así como los autores que participaron en estas investigaciones. Revisamos los artículos publicados sobre el tema desde los inicios del siglo XX. Hacemos un recuento especial sobre la píldora anticonceptiva, cómo se gesto su descubrimiento y cómo se interrelaciona ésta con el lupus, al igual que las demás hormonas. Finalmente hacemos un recuento de las principales investigaciones que se realizan entre las hormonas y el lupus.

Palabras clave:
lupus eritematoso sistémico
hormonas
estrógenos
testosterona
píldora anticonceptiva
Summary

In this paper we present the diverse events leading up to know in depth the relationship between hormones and lupus, and the authors who participated in this research. We reviewed published articles on the subject since the early twentieth century. We especially count on the birth control pill, how it was discovered and how this interacts with lupus, as well as other hormones. Finally we review the major research being conducted between hormones and lupus

Key words:
systemic lupus erythematosus
hormones
estrogens
testosterone
birth control pill
El Texto completo solo está disponible en PDF
Referencias
[1.]
G. Baehr, P. Klemperer, A. Schifrin.
A Diffuse Disease of the Peripheral Circulation Usually Associated with Lupus Erythematosus and Endocarditis.
Trans. Ass Amer Physicians, 50 (1935), pp. 139-155
[2.]
A. Mattras.
Zur Symtomatologie und klinik födlich verlaufender fälle von Lupus Erythematosus.
Arch f. Dermat. u syph, (1938), pp. 223-235
[3.]
H. Keil.
Dermatomyositis and Systemic Lupus Erythematosus II. Comparative Study of Essential Clinicopathologie Features.
Arch Intern Med, 66 (1940), pp. 339-383
[4.]
E. Rose, D.M. Pillsbury.
Lupus Erythematosus (Erythematodes) and Ovarian Function; Observations on Possible Relationship with Report of 6 cases.
Ann Intern Med, 21 (1944), pp. 1022-1034
[5.]
S. Jarchos.
Lupus Erythematosus Associated with visceral Vascular Lesions; seriesof Autopsied Cases.
Bull. Johns Hopkins Hospi, 59 (1936), pp. 262-273
[6.]
E.L. Dubois, R.R. Commons, P. Star, C.S. Stein, R. Morrison.
Corticotropin and Cortisone Treatment for Systemic Lupus Erythematosus.
JAMA, 149 (1952), pp. 995-1002
[7.]
W.W. Engstrom, P.L. Munson.
Studies on the Metabolism of Testosterone in Normal Women in Different Phases of the Menstrual Cycle.
J Clin Endocr, 11 (1951), pp. 427-433
[8.]
J.H. Lamb, E.S. Lain, C. Keaty, A. Hellbaum.
Steroid Hormones; Metabolic Studies in Dermatomyositis.
Lupus Erithematosus, and Polymorphic Light-Sensitive Eruptions. Arch Derm, 57 (1948), pp. 785-801
[9.]
P. Koets.
Excretion of Urinary 17 Ketosteroids in Chronic Lupus Erythematosus: Case Report.
Stanford Med Bull, 9 (1951), pp. 256-259
[10.]
P.R.J. Burch, N.R. Rowell.
Autoimmunity A etiological Aspects of Chronic Discoid and Systemic Lupus Erythematosus, Systemic Sclerosis, and Hashimoto's Thyroiditis. Some Immunological Implications.
Lancet, 2 (1963), pp. 507-513
[11.]
P.R.J. Burch, N.R. Rowell.
Systemic Lupus Erythematosus. Etiological Aspects.
Amer J Med, 38 (1965), pp. 793-801
[12.]
R.E. Kellum, J.R. Haserick.
Systemic Lupus Erythematosus. A Statistical Evaluation of Mortality Based on a Consecutive Series of 299 patients.
Arch Int Med, 113 (1964), pp. 200-207
[13.]
A. Iglesias-Gamarra.
Historia del lupus Editorial Panamericana. Formas e impresos.
Bogotá agosto de, (2003),
[14.]
W.H. Finley, S.C. Finley, W.P. Beetham, H.L. Holley.
Chromosome Studies in Systemic Lupus Erythematosus (SLE).
Abs. Arthritis Rheum, 7 (1964), pp. 307
[15.]
A. Mund, J. Simson, N. Rothfield.
Effect of pregnancy on course of systemic lupus erythematosus.
JAMA, 183 (1963), pp. 917-920
[16.]
E.L. Dubois.
Lupus Erythematosus.
University of Southern California Press, (1974), pp. 137
[17.]
R. Stern, J. Fishman, H. Brushman, H.G. Kunkel.
Systemic lupus Erythematosus associated with Klinefelter's syndrome.
Arthritis Rheum, 20 (1977), pp. 18-22
[18.]
M.A.H. French, P. Hughes.
Systemic lupus Erythematosus and Klinefelter’s syndrome.
Ann Rheum Dis, 42 (1983), pp. 471-473
[19.]
H. Ellis.
Marie Carmichael Stopes: Pioneer of birth control for women.
Brit J Hosp Med, 69 (2008), pp. 595
[20.]
G. Pincus.
The Control of Fertility.
Academic Press, (1965),
[21.]
J.H. Lamb, E.S. Lain, C. Keaty, A. Hellbaum.
Steroid Hormones; Metabolic Studies in Dermatomyositis. Lupus Erithematosus, and Polymorphic Light-Sensitive Eruptions.
Arch Derm, 57 (1948), pp. 785-801
[22.]
T. Pederson.
A Good Man: Gregory Goodwing Pincus.
The FASEB Journal, 23 (2009), pp. 2341-2344
[23.]
L. Marks.
Historia de la píldora anticonceptiva.
Ciencias, 48 (1997), pp. 33-39
[24.]
S. Ansar, W.J. Penhale, N. Talal.
Sex Hormones. Immune Responses, and Autoimmune Diseases Mechanism of Sex Hormone Action.
Am J Pathol, 121 (1985), pp. 531-551
[25.]
M.A. Shampo, R.A. Kyle, John Rock:.
Pionner in the Development of Oral Contraceptives.
Mayo Clin Proc, 79 (2004), pp. 844
[26.]
Advisory Committee on Obstetrics and Gynecology.
Report on the Oral Contraceptives”. Food and Drugs Administration.
U.S. Department of Health, Education and Welfare, (1969),
[27.]
L.M. Hellman.
The Oral Contraceptives in Clinical Practice.
Family Planning Perspectives, 1 (1969), pp. 13-17
[28.]
Advisory Committee on Obstetrics and Gynecology.
Report on the Oral Contraceptives Food and Drugs Administration.
U.S. Department of Health, Education and Welfare, (1966),
[29.]
Mintz M.The Pill. Columbia Journalism Review (in two parts: Winter 1968-1969 and Spring 1969)
[30.]
L. Haberlandt.
A pioneer in hormonal contraception.
Wien Klin Wochenschr, 121 (2009), pp. 746-749
[31.]
C. Noe.
Gottlieb Haberlandt.
Plant Physiol, 9 (1934), pp. 850-855
[32.]
L. Haberlandt.
Über Hormonales Sterilisierung des weiblichen Tierkörpers (Vorläufige Mitteilung).
Münch Med Wochenschr, 49 (1921), pp. 1577-1578
[33.]
L. Haberlandt.
Über Hormonales Sterilisierung weiblicher Tiere durch subcutane Transplantation von Ovarien trächtiger Weibchen.
Pflüger Arch, 194 (1922), pp. 235-270
[34.]
L. Haberlandt, G. Fischer.
Die Hormonale Sterilisierung des weiblichen Organismus, (1931),
[35.]
L. Haberlandt, A. Erwiderung auf, Greils.
Einwände gegen die hormonale Sterilisierung nach Haberlandt.
Zbl Gynäkol, 22 (1924), pp. 1197-1198
[36.]
Haberlandt L. Ein Jahresbuch I. (Unveröffentlichte Autobiographie. Mit einem Nachtrag von W.F. und R. Haberlandt) 1985-1930.
[37.]
H.H. Simmer.
On the history of hormonal contraception I. Ludwinng Haberlandt and his concept of hormonal sterilization.
Contraception, 1 (1970), pp. 1-27
[38.]
H.H. Simmer, I.I. On the history of hormonal contraception.
Ortfried O Fellner and estrogens as antifertility hormones.
Contraception, 3 (1971), pp. 1-20
[39.]
W. Frobenius, C. Djerassi.
Die Erfindung der pille und der Paradigmenwechsel in der Wissenschaft- Anmekungen zu einem Jubiläum mit zweifelhaftem Datum.
Geburtsh Frauenheilk, 62 (2002), pp. 849-855
[40.]
E. Lesky.
Ein Pionier der hormonalen Antikonzeption. Ludwing Haberlandt.
Österr Ärztez, 9 (1975),
[41.]
E. Lesky, L. Haberlandt.
Urvater der Ovulationshemmung.
Der Prakt Arzt, 10 (1988), pp. 1567
[42.]
W.D. Müller Jahne.
Ludwing Haberlandt and the development of hormonal contraception.
Z Gesamte Inn Med, 43 (1988), pp. 420-422
[43.]
C. Djerassi, contraception. Steroid oral.
The chemical developments which led to the currently employed steroid contraceptive agents are reviewed.
Science, 151 (1966), pp. 1055-1061
[44.]
http://grafik.rp.pl/grafika2/478376,489893,3.jpg (consultado en octubre 10 de 2010).
[45.]
S.H. Sturgid, F. Albright.
The mechanism of estrin therapy in the relief of dysmenorrhoea.
Endocrinology, 26 (1940), pp. 68-72
[46.]
A.W. Makepeace, G.L. Winstein, M.H. Freedman.
The effect of progestin and progesterone on ovulation in the rabbit.
American Journal Of Physiology, 119 (1937), pp. 512-516
[47.]
J. Rock, G.G. Pincus, C.R. Garcia.
Effects of certain 19- norsteroids on the human menstrual cycle.
Science, 124 (1956), pp. 891-893
[48.]
G.T. Kovacs.
Pharmacology of progestogens used in oral contraceptives: An historical review to contemporary prescribing.
Australian and New Zealand Journal of Obstetrics and Gynaecology, 43 (2003), pp. 4-9
[49.]
Djerassi Carl.
Chemical birth of the pill.
Am J Obstet Gynecol, 194 (2006), pp. 290-298
[50.]
W.M. Allen, M. Ehrenstein.
19-Norprogesterone, a physiologically active lower homolog of progesterone.
Science, 100 (1944), pp. 251-252
[51.]
A.J. Birch.
Hydroaromatic steroids: part 1, 10- Nortestosterone.
J Chem Soc, (1950), pp. 367-368
[52.]
C. Djerassi, L. Miramontes, G. Rosenkranz.
19- Norprogesterone, a potent progestational hormone.
J Am Chem Soc 1953, 75 (1951), pp. 4440-4442
[53.]
H.H. Inhoffen, W. Logemann, W. Hohlweg, A. Serini.
Untersuchungen in der sexualhormon-Reihe.
Chem Ber, 71 (1938), pp. 1024-1032
[54.]
C. Djerassi, L. Miramontes, G. Rosenkranz.
19-Nor-17aethynyltestosterone and 19-nor-17a-methyltestosterone. [Abstracts, p.18-JG.] Division of Medicinal Chemistry.
American Chemical Society Semi-annual Meeting, Milwaukee, Wisc, (1952),
[55.]
C. Djerassi, L. Miramontes, G. Rosenkranz, F. Sondheimer.
Synthesis of 19-nor-17a-ethynyltestosterone and 19- nor-17a-methyltestosterone.
J Am Chem Soc, 76 (1954), pp. 4092-4094
[56.]
Colton FB. US Patent 2,725,389. August 31,1953
[57.]
E.T. Tyler.
Comparative evaluation of various types of administration of progesterone.
J Clin Endocrinol Metab, 15 (1955), pp. 881
[58.]
J. Rock, C.R. Garcia, G. Pincus.
Synthetic progestogens in the normal human menstrual cycle.
Recent Progr Horm Res, 13 (1957), pp. 323-326
[60.]
M.H. Hart.
The 100: A Ranking of the Most Influential Persons in History.
Cita del Press, (1978),
[61.]
G. Alonso.
Historia de la anticoncepción.
Rev Cubana Med, (1995),
[63.]
O. Hechter.
Homage to Gregoy Pincus.
Perspectives Biol Med, 11 (1968), pp. 358-370
[64.]
C. Djerassi.
This Man‘s Pill: Reflections on the 50th Anniversary of the Pill.
Oxford University Press, (2001),
[65.]
http://www.todayinsci.com/R/Rock_John/RockJohnThm. jpg (consultado en octubre 10 de 2010).
[66.]
Royal College of General Practitioners. Oral contraception study: mortality among oral contraceptive users. Lancet II, 727
[67.]
T.A. Chapel, R.E. Burns.
Oral contraceptives and exacerbations of lupus Erythematosus.
Am J Obstet Gynecol, 110 (1971), pp. 366-369
[68.]
E.M. Schleicher.
LE cells after oral contraceptives.
Lancet, 1 (1968), pp. 821-822
[69.]
H. Spiera, C.M. Plotz.
Rheumatic symptoms and oral contraceptives.
Lancet, 1 (1969), pp. 571-572
[70.]
C.H. McKenna, K.C. Weiman, L.E. Schulman.
Oral contraceptives, rheumatic diseases, and autoantibodies.
Arthritis Rheum, 12 (1969), pp. 313-314
[71.]
M. Garovich, C. Agudelo, E. Pisko.
Orla contraceptives and systemic lupus Erythematosus.
Arthritis Rheum, 23 (1980), pp. 1396-1398
[72.]
P. Jungers, M. Dougados, C. Pelissier, K. Nahoul, F. Tron, J.F. Bach.
Influence of oral contraceptives therapy on the activity of systemic lupus Erythematosus.
Arthritis Rheum, 25 (1982), pp. 618-623
[73.]
J.L. Beaumont, N. Lemort, E.L. Lorenzelli, B. Delplanque, V. Beaumont.
Antiethinyloestradiol antibody activities in oral contraceptive users.
Clin Exp Immunol, 38 (1979), pp. 445
[74.]
V. Beaumont, N. Lemort, J.L. Beaumont.
Oral contraception, circulating immune complexes, antiethinylestradiol antibodies and thrombosis.
Am J Reprod Immunol, 2 (1982), pp. 8
[75.]
R.G. Lahita, H.L. Bradlow, H.G. Kunkel, J. Fishman.
Anterations of estrogen metabolism in systemic lupus Erythematosus.
Arthritis Rheum, 22 (1979), pp. 1195
[76.]
R.G. Lahita, H.L. Bradlow, H.G. Kunkel, J. Fishman.
Increased 16á-hydroxylation of estradiol in systemic lupus Erythematosus.
J Clin Endocrinol Metab, 53 (1981), pp. 174
[77.]
R. Bucala, J. Fishman, A. Cerami.
Formation of covalent adducts between cortisol and 16á- hydroxyestrone and prote possible role in the pathogenesis of cortisol toxicity systemic lupus Erythematosus.
Proc Natn Acad Sci. USA, 79 (1982), pp. 3320
[78.]
R. Bucala, J. Fishman, A. Cerami.
The reaction of 16áhydroxyestrone with erythrocytes in vitro and in vivo.
Eur J Biochem, 140 (1984), pp. 593
[79.]
R. Bucala, R.G. Lahita, J. Fishman, C. Cerami.
increased levels of 16á-hydroxyestrone modified proteins in pregnancy and in systemic lupus erytematosus.
J Clin Endocrinol Metab, 60 (1985), pp. 841
[80.]
R.G. Lahita, R. Bucala, H.L. Bradlow, K. Fishman.
Determination of 16ÁOHE-hydroxyestrone by RIA in systemic lupus Erythematosus.
Arthritis. Rheum, 28 (1985), pp. 1122
[81.]
R. Bucala, P.C. Ulrich, B.T. Chait, F.A. Bencsath, A. Cerami.
Structure of Lysine adducts with 16á-hydroxyestrone and cortisol.
J Steroid Biochem, 25 (1986), pp. 127
[82.]
R. Bucala, R.G. Lahita, J. Fishman, A. Cerami.
Antioestrogen antibodies in users of oral contraceptives and patients with systemic lupus Erythematosus.
Clin Exp Immunol, 67 (1987), pp. 167-175
[85.]
N. Talal.
Natural history of murine lupus. Modulation by sex hormones.
Arthritis Rheum, 21 (1978), pp. S58-S63
[86.]
N. Talal.
Immunologic and viral factors in the pathogenesis of systemic lupus erythematosus.
Arthritis Rheum, 13 (1970), pp. 887-893
[87.]
J.A. Levy.
Autoimmunity and neoplasia:the possible role of C-type viruses.
Am J Clin Pathol, 62 (1974), pp. 258-280
[88.]
J.B. Howie, B.J. Helyer.
The immunology and pathology of NZB mice.
Adv Immunol, 9 (1968), pp. 215-266
[89.]
M.M. Evans, W.G. Williamson, W.J. Irvine.
The appearance of immunological competence at an early age in New Zealand black mice.
Clin Exp Immunol, 3 (1968), pp. 375-383
[90.]
A.D. Steinberg, S.H. Baron, N. Talal.
The pathogenesis of autoimmunity in New Zealand mice. 1. Induction of antinucleic acid antibody in polyinosinic. polycytidylic acid.
Proc Nat Acad Sci USA, 63 (1969), pp. 1102-1107
[91.]
P.J. Staples, A.D. Steinberg, N. Talal.
Induction of immunological tolerance in older New Zealand mice repopulated with young spleen, bone marrow, or thymus.
J Exp Med, 131 (1970), pp. 123-128
[92.]
T. Shirai, R.C. Mellors.
Natural cytotoxic autoantibody and reactive antigen in New Zealand Black and other mice.
Proc Nat Acad Sci USA, 68 (1971), pp. 1412-1415
[93.]
D.R. Barthold, S. Kysela, A.D. Steinberg.
Decline in suppressor T cell function with age in female NZB mice.
J Immunol, 112 (1974), pp. 9-16
[94.]
F.M. Burnet, M.C. Holmes.
The natural history of the NZB/NZW F1 hybrid mouse: a laboratory model of systemic lupus erythematosus.
Australas Ann Med, 14 (1965), pp. 185-191
[95.]
J.R. Roubinian, R. Papoian, N. Talal.
Androgenic hormones modulate autoantibody responses and improve survival in murine lupus.
J Clin Invest, 59 (1977), pp. 1066-1070
[96.]
A.D. Steinberg, K.A. Melez, E.S. Raveche, et al.
Approach to the study of the role of sex hormones in autoimmunity.
Arthritis Rheum, 22 (1979), pp. 1170-1176
[97.]
N. Talal.
Animal models for systemic lupus Erythematosus.
Clin Rheum Dis, 1 (1951), pp. 485
[98.]
N. Talal.
Sex steroid hormones and systemic lupus Erythematosus.
Arthritis Rheumatism, 24 (1981), pp. 1054
[99.]
N. Talal, M. Dauphinée, S.A. Ahmed, P. Christadoss.
Sex factors in immunity and autoimmunity. Progress in immunology, pp. 1589-1600
[100.]
S.A. Ahmed, M.J. Dauphinee, N. Talal.
Effects of shortterm administration of sex hormones on normal and autoimmune mice.
J Immunol, 134 (1985), pp. 204
[101.]
D. Eidinger, T.J. Garrett.
Studies of the regulatory effects of the sex hormones on antibody formation and stem cell differentiation.
J Exp Med, 136 (1972), pp. 1098-1116
[102.]
R.G. Lahita, H.L. Bradlow, H.G. Kunkel, J. Fishman.
Alterations of estrogen metabolism in systemic lupus erythematosus.
Arthritis Rheum, 22 (1979), pp. 1195-1198
[103.]
R.G. Lahita, H.L. Bradlow, H.G. Kunkel, J. Fishman.
Increased 16 alpha-hydroxylation of estradiol in systemic lupus erythematosus.
J Clin Endocrinol Metab, 53 (1981), pp. 174-178
[104.]
R. Stern, J. Fishman, H. Brusman, H.G. Kunkel.
Systemic lupus erythematosus associated with klinefelter's syndrome.
Arthritis Rheum, 20 (1977), pp. 18-22
[105.]
E.M. Schleicher.
LE cells after oral contraceptives.
Lancet, 1 (1968), pp. 821-822
[106.]
M. Garovich, C. Agudelo, E. Pisko.
Oral contraceptives and systemic lupus erythematosus.
Athritis Rheum, 23 (1980), pp. 1396-1398
[107.]
P. Jungers, M. Dougados, C. Pelissier, K. Nahoul, F. Tron, J.-F. Bach.
Influence of oral contraceptive therapy on the activity of systemic lupus erythematosus.
Arthritis Rheum, 25 (1982), pp. 618-623
[108.]
J. Sánchez-Guerrero, A.G. Uribe, L. Jiménez-Santana, et al.
A trial of contraceptive methods in women with systemic lupus erythematosus.
N Engl J Med, 353 (2005), pp. 2539-2549
[109.]
M. Petri, M.Y. Kim, K.C. Kalunian, et al.
Combined oral contraceptives in women with systemic lupus erythematosus.
N Engl J Med, 353 (2005), pp. 2550-2558
[110.]
J.P. Buyon, M.A. Petri, M.Y. Kim, et al.
The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial.
Ann Intern Med, 142 (2005), pp. 953-962
[111.]
J.P. Buyon.
Hormone replacement therapy in postmenopausal women with systemic lupus erythematosus.
J Am Med Womens Assoc, 53 (1998), pp. 13-17
Copyright © 2011. Asociación Colombiana de Reumatología
Opciones de artículo
Herramientas
es en pt
Política de cookies Cookies policy Política de cookies
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.